Correlation of factors between subscales of the Japanese version of the Substance Use Stigma Mechanism Scale (N = 126).

Snapshot img

Paracetamol Market Size 2025-2029

The paracetamol market size is forecast to increase by USD 1.07 billion at a CAGR of 10% between 2024 and 2029.

Paracetamol, a widely used over-the-counter (OTC) medication, exhibits promising growth in the global market. Key factors fueling this expansion include the substantial utilization of paracetamol as an active pharmaceutical ingredient (API) in numerous OTC drugs. Paracetamol is available in various forms, such as capsules, liquids, powders, rectal, intravenous, and intravenous paracetamol. Additionally, there is a rising preference for extended-release formulations due to their enhanced efficacy and patient compliance. However, concerns over the potential adverse effects of analgesics, particularly liver toxicity, pose a significant challenge to market growth. Manufacturers need to address these concerns through rigorous safety testing and innovative formulations to ensure consumer safety and trust. In summary, the market is driven by its extensive use in OTC drugs and the increasing demand for extended-release formulations, while facing challenges due to safety concerns.

What will be the Size of the Paracetamol Market During the Forecast Period?

Request Free Sample

Paracetamol, also known as acetaminophen, is a widely used pain reliever and antipyretic in the healthcare industry. The drug's popularity can be attributed to its effectiveness in managing various types of pain, including migraines, chronic daily headaches, and chronic pain in the elderly. In France, the Reliance Program ensures the availability and accessibility of essential medicines, including paracetamol, to the population. The regulatory authority oversees the production, distribution, and use of paracetamol and other pain management drugs.



Paracetamol's versatility extends to the treatment of conditions like the flu, menstrual periods, toothaches, backaches, and osteoarthritis. Its antipyretic properties make it an effective fever reducer. The drug's long-term use, particularly in the elderly, raises concerns regarding its potential impact on longevity. The Migraine Trust highlights the importance of effective pain management for individuals suffering from chronic conditions like migraines. Paracetamol, when used appropriately, can provide relief for these patients. However, it is essential to consider the potential side effects and interactions with other medications before use. Intravenous paracetamol is an alternative administration route for patients who cannot take the drug orally. This form of paracetamol is particularly useful in hospitals and healthcare settings where patients require immediate pain relief. In conclusion, paracetamol remains a crucial pain management drug in the healthcare industry, with applications ranging from common ailments to chronic conditions. Regulatory authorities play a vital role in ensuring its safe and effective use, while ongoing research explores new ways to optimize its benefits and minimize potential risks.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Surgical
  Non-surgical


Formulation

  Powder
  Granules


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The surgical segment is estimated to witness significant growth during the forecast period.

Paracetamol, a commonly used over-the-counter analgesic and antipyretic, finds extensive application in managing various health conditions. In the medical sphere, it is particularly effective in alleviating backaches, osteoarthritis pain, and fever. For instance, it is often prescribed for individuals suffering from migraines, a condition managed by the Migraine Trust.

Additionally, paracetamol is beneficial for patients with diabetes, epilepsy, asthma, and oral diseases, including toothache. In surgical settings, paracetamol is administered intravenously or orally for postoperative pain management. Its usage in the perioperative period reduces the requirement for opioids, thereby mitigating the risks associated with their use. Paracetamol's widespread utility and effectiveness make it an indispensable component in healthcare.

Get a glance at the market report of share of various segments Request Free Sample

The surgical segment was valued at USD 671.60 million in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 39% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the r